SB 37 - This act provides a sales tax exemption for all purchases of feminine hygiene products, defined as tampons, pads, liners, and cups.

This act is identical to SB 793 (2024), SB 433 (2023), and SB 897 (2022), and to a provision in SB 858 (2024), SB 1119 (2024), HB 1762 (2024), HB 1920 (2024), HB 2112 (2024), SS/SCS/SBs 73 & 162 (2023), and SCS/HCS/HB 154 (2023), is substantially similar to HB 351 (2023) and HCS/HBs 1679 (2022), 2859, & 2272 (2022), and to a provision in HB 2187 (2024), HCS/SS/SB 143 (2023), HCS/HBs 876, 771, 676 & 551 (2023), and HB 1136 (2023), and is similar to SB 800 (2020), HCS/HBs 1306 & 2065 (2020), SB 443 (2019), and HB 747 (2019), and to a provision contained in HCS/SS/SCS/SB 570 (2020).

JOSH NORBERG

Statutes affected:
Introduced (0811S.01): 144.030


Senate Committee Minutes:
SENATE COMMITTEE MINUTES Bill No.: SB 37
Sponsor: Washington
Hearing Date: 3/5/2025


COMMITTEE: Economic and Workforce Development

CHAIRMAN: Brown (26)

DATE REFERRED: 1/16/2025 DATE HEARING REQUESTED: 2/27/2025



STAFF:
Frank Catanzaro
Hannah Embry
Josh Norberg


WITNESSES GIVING INFORMATION:



WITNESSES FOR:
Curt Wichmer - Missouri Catholic Conference
Sarah Schlemeier - American College of Obstetricians and Gynecologists and Haleon
Michael Henderson - Consumer Healthcare Products Association


WITNESSES AGAINST: